.png){kind=logo}
Stock image for illustration purposes only - book cover, edition or condition may vary.
Metalloproteinases as Targets for Anti-Inflammatory Drugs
. Ed(S): Bottomley, Kevin M.K.; Nixon, John S.
€ 248.62
FREE Delivery in Ireland
Description for Metalloproteinases as Targets for Anti-Inflammatory Drugs
Paperback. Editor(s): Bottomley, Kevin M.K.; Nixon, John S. Series: Progress in Inflammation Research. Num Pages: 219 pages, biography. BIC Classification: MB. Category: (P) Professional & Vocational. Dimension: 235 x 155 x 12. Weight in Grams: 349.
This volume describes recent research in the field of metalloproteinases (a family of enzymes that can catalyze tissue degradation), in particular their participation in autoimmune diseases such as rheumatoid arthritis, reviewing the latest developments in metalloproteinase inhibitor design and the current status of clinical candidates. This volume is intended not only for those active in research into metalloproteinases but also for those with an interest in inflammatory diseases. Thus it addresses both academic and industrial researchers.
This volume describes recent research in the field of metalloproteinases (a family of enzymes that can catalyze tissue degradation), in particular their participation in autoimmune diseases such as rheumatoid arthritis, reviewing the latest developments in metalloproteinase inhibitor design and the current status of clinical candidates. This volume is intended not only for those active in research into metalloproteinases but also for those with an interest in inflammatory diseases. Thus it addresses both academic and industrial researchers.
Product Details
Format
Paperback
Publication date
2012
Publisher
Springer Basel Switzerland
Number of pages
219
Condition
New
Series
Progress in Inflammation Research
Number of Pages
207
Place of Publication
Basel, Switzerland
ISBN
9783034897242
SKU
V9783034897242
Shipping Time
Usually ships in 15 to 20 working days
Ref
99-15
Reviews for Metalloproteinases as Targets for Anti-Inflammatory Drugs